Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | SGVector |
Description | SGVector is helping to address the global shortage in viral Addressing the global shortage in viral |
Keywords | N/A |
WebSite | sgvector.com |
Host IP | 160.153.0.131 |
Location | United States |
Site | Rank |
US$1,592
Last updated: 2023-05-20 08:23:48
sgvector.com has Semrush global rank of 0. sgvector.com has an estimated worth of US$ 1,592, based on its estimated Ads revenue. sgvector.com receives approximately 183 unique visitors each day. Its web server is located in United States, with IP address 160.153.0.131. According to SiteAdvisor, sgvector.com is safe to visit. |
Purchase/Sale Value | US$1,592 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$44 |
Yearly Ads Revenue | US$529 |
Daily Unique Visitors | 12 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
sgvector.com. | A | 3600 | IP: 160.153.0.131 |
sgvector.com. | NS | 3600 | NS Record: ns75.domaincontrol.com. |
sgvector.com. | NS | 3600 | NS Record: ns76.domaincontrol.com. |
sgvector.com. | MX | 3600 | MX Record: 0 sgvector-com.mail.protection.outlook.com. |
sgvector.com. | TXT | 3600 | TXT Record: v=spf1 include:secureserver.net -all |
sgvector.com. | TXT | 3600 | TXT Record: google-site-verification=XJXmkA72t7zb-NfjStqIv_rJSoUmkdQxdDT0gL8B1bA |
sgvector.com. | TXT | 3600 | TXT Record: D6705167 |
sgvector.com. | TXT | 3600 | TXT Record: ca3-ba4cbef5805842c689da09971dc8666a |
sgvector.com. | TXT | 3600 | TXT Record: NETORGFT11386454.onmicrosoft.com |
Contact Us SGVector is helping to address the global shortage in viral vectors What we aim to do Establish Viral Vector suspension-based scale manufacturing process/technologies in Singapore. Set up and operate a modular cGMP facility for the development and production of viral vectors for gene therapies. Demand The FDA continues with strong support of Innovation in Development of Gene Therapy Products. The agency anticipates many more approvals in the coming years, as evidenced by the circa 1000 Investigational New Drug applications for ongoing clinical studies in this area. The agency believes this will provide patients and providers with increased therapeutic choices. The growth of innovative research and product development in the field of gene therapy is exciting. These therapies are rapidly becoming a therapeutic reality for an increasing number of patients with a wide range of diseases, including rare genetic disorders and autoimmune diseases. The FDA is expecting a gene |
HTTP/1.1 301 Moved Permanently Date: Thu, 26 Jan 2023 09:31:10 GMT Content-Type: text/html; charset=iso-8859-1 Connection: keep-alive Content-Security-Policy: upgrade-insecure-requests Location: https://sgvector.com/ Vary: User-Agent, Accept-Encoding X-Backend: local X-Cache: cached X-Cache-Hit: HIT X-Cacheable: YES:Forced X-Cacheproxy-Retries: 0/2 X-Content-Type-Options: nosniff X-Php-Version: 7.4 X-Xss-Protection: 1; mode=block CF-Cache-Status: HIT Expires: Sun, 26 Feb 2023 09:31:10 GMT Cache-Control: public, max-age=2678400 Server: cloudflare CF-RAY: 78f83bed6859bbbc-FRA alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400 HTTP/2 200 date: Thu, 26 Jan 2023 09:31:10 GMT content-type: text/html; charset=UTF-8 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 strict-transport-security: max-age=31536000; includeSubDomains vary: Accept-Encoding, User-Agent x-backend: local x-cache: uncached x-cache-hit: MISS x-cacheable: YES:Forced x-cacheproxy-retries: 0/2 x-content-type-options: nosniff x-fawn-proc-count: 1,0,24 x-php-version: 7.4 x-xss-protection: 1; mode=block last-modified: Tue, 24 Jan 2023 11:54:34 GMT cf-cache-status: HIT expires: Sun, 26 Feb 2023 09:31:10 GMT cache-control: public, max-age=2678400 server: cloudflare cf-ray: 78f83bef886b2c18-FRA alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400 |